These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9446950)
41. Sphincter preservation in four consecutive phase II studies of preoperative chemoradiation: analysis of 247 T3 rectal cancer patients. Gambacorta MA; Valentini V; Coco C; Manno A; Doglietto GB; Ratto C; Cosimelli M; Miccichè F; Maurizi F; Tagliaferri L; Mantini G; Balducci M; La Torre G; Barbaro B; Picciocchi A Tumori; 2007; 93(2):160-9. PubMed ID: 17557563 [TBL] [Abstract][Full Text] [Related]
42. Combined radiation and chemotherapy of resectable stage II-III carcinoma of mid-lower rectum: preliminary results. Valentini V; Coco C; De Santis M; Trodella L; Vecchio FM; Cellini N Rays; 1993; 18(3):428-31. PubMed ID: 8284460 [No Abstract] [Full Text] [Related]
43. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients. Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515 [TBL] [Abstract][Full Text] [Related]
44. Sphincter preservation in patients with low rectal cancer treated with radiation therapy with or without local excision or fulguration. Rich TA; Weiss DR; Mies C; Fitzgerald TJ; Chaffey JT Radiology; 1985 Aug; 156(2):527-31. PubMed ID: 4011919 [TBL] [Abstract][Full Text] [Related]
54. Conservative management of rectal carcinoma: the efficacy of a multimodality approach. Jessup JM; Bleday R; Busse P; Steele G Semin Surg Oncol; 1993; 9(1):39-45. PubMed ID: 8356384 [TBL] [Abstract][Full Text] [Related]
55. [Experience of surgical treatment of rectal cancer with chemoradiation component on the first stage]. Peliukhovs'kyĭ SV; Chornobaĭ AV Klin Khir; 2004 Jan; (1):37-8. PubMed ID: 15071997 [TBL] [Abstract][Full Text] [Related]
56. Adjuvant therapy for rectal cancer in the elderly. Cohen SM; Neugut AI Drugs Aging; 2004; 21(7):437-51. PubMed ID: 15132712 [TBL] [Abstract][Full Text] [Related]
57. Organ preservation in rectal adenocarcinoma (T1) T2-T3 Nx M0. Historical overview of the Lyon Sud - nice experience using contact x-ray brachytherapy and external beam radiotherapy for 120 patients. Gerard JP; Frin AC; Doyen J; Zhou FX; Gal J; Romestaing P; Barbet N; Coquard R; Chapet O; François E; Marcié S; Benezery K Acta Oncol; 2015 Apr; 54(4):545-51. PubMed ID: 25389568 [No Abstract] [Full Text] [Related]
58. Renaissance of contact x-ray therapy for treating rectal cancer. Gérard JP; Myint AS; Croce O; Lindegaard J; Jensen A; Myerson R; Hannoun-Lévi JM; Marcie S Expert Rev Med Devices; 2011 Jul; 8(4):483-92. PubMed ID: 21728733 [TBL] [Abstract][Full Text] [Related]
59. Californium-252 neutron intracavity brachytherapy alone for T1N0 low-lying rectal adenocarcinoma: A definitive anal sphincter-preserving radiotherapy. Xiong Y; Shan J; Liu J; Zhao K; Chen S; Xu W; Zhou Q; Yang M; Lei X Sci Rep; 2017 Jan; 7():40619. PubMed ID: 28094790 [TBL] [Abstract][Full Text] [Related]
60. [Antiblastic therapy of nonadvanced colorectal cancer: preliminary results of a randomized therapeutic trial]. Bertoldi I; Barzi A; Cavaleri V; D'Avena C; De Vecchis L; Mangialardi N; Chirletti P Ann Ital Chir; 1982; 54(1):77-85. PubMed ID: 6756248 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]